NCT02651753View on ClinicalTrials.gov

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions
Dyslipidemia
Interventions
DRUG

Lipitor + Lipidil supra

Reference Drug: Lipitor + Lipidil supra

DRUG

CKD-337

Test Drug: CKD-337

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02651753 - A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | Biotech Hunter | Biotech Hunter